Loomis, Sayles & Company
ALKS icon

Loomis, Sayles & Company’s Alkermes ALKS Stock Holding History

Loomis, Sayles & Company’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.1M Sell
1,585,518
-199,063
-11% -$7.77M 0.1% 74
2026
Q1 		$63.1M Sell
1,784,581
-117,941
-6% -$3.66M 0.08% 81
2025
Q4 		$53.2M Sell
1,902,522
-146,329
-7% -$4.38M 0.06% 101
2025
Q3 		$61.5M Sell
2,048,851
-61,043
-3% -$1.72M 0.07% 91
2025
Q2 		$60.4M Sell
2,109,894
-330,389
-14% -$9.83M 0.08% 91
2025
Q1 		$80.6M Buy
2,440,283
+137,378
+6% +$4.48M 0.12% 73
2024
Q4 		$66.2M Buy
2,302,905
+419,969
+22% +$12.1M 0.08% 90
2024
Q3 		$52.7M Buy
1,882,936
+1,478,422
+365% +$39.4M 0.07% 126
2024
Q2 		$9.75M Sell
404,514
-362,563
-47% -$8.89M 0.01% 363
2024
Q1 		$20.8M Sell
767,077
-5,120
-0.7% -$145K 0.03% 258
2023
Q4 		$21.4M Buy
772,197
+86,270
+13% +$2.24M 0.03% 243
2023
Q3 		$19.2M Buy
685,927
+317,920
+86% +$9.32M 0.03% 247
2023
Q2 		$11.5M Buy
368,007
+37,013
+11% +$1.12M 0.02% 321
2023
Q1 		$9.33M Buy
+330,994
New +$9.02M 0.02% 340
2016
Q1 		– Sell
-32,638
Closed -$2.59M – 1052
2015
Q4 		$2.59M Buy
32,638
+18,718
+134% +$1.31M 0.01% 528
2015
Q3 		$817K Buy
13,920
+1,859
+15% +$123K ﹤0.01% 569
2015
Q2 		$776K Sell
12,061
-537
-4% -$32.9K ﹤0.01% 588
2015
Q1 		$768K Buy
12,598
+10,839
+616% +$741K ﹤0.01% 615
2014
Q4 		$103K Sell
1,759
-10
-0.6% -$509 ﹤0.01% 663
2014
Q3 		$76K Hold
1,769
– – ﹤0.01% 678
2014
Q2 		$89K Sell
1,769
-26
-1% -$1.2K ﹤0.01% 691
2014
Q1 		$79K Sell
1,795
-1,478,397
-100% -$70.3M ﹤0.01% 686
2013
Q4 		$60.2M Buy
1,480,192
+605,497
+69% +$22.4M 0.18% 126
2013
Q3 		$29.4M Sell
874,695
-4,774
-0.5% -$155K 0.1% 219
2013
Q2 		$25.2M Buy
+879,469
New +$25.6M 0.09% 240

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Loomis, Sayles & Company's ALKS Position: Q2 2026 in Review

Loomis, Sayles & Company reduced its Alkermes (ALKS) stake by 11% in Q2 2026, selling an estimated $7.77M and leaving 1,585,518 shares worth $83.1M. The position accounts for 0.1% of the portfolio, ranked #74.

Loomis, Sayles & Company first reported a position in ALKS in Q2 2013 and has held it in 25 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Loomis, Sayles & Company held 1,585,518 shares of Alkermes worth $83.1M as of Q2 2026.
  • Loomis, Sayles & Company sold 199,063 Alkermes shares in Q2 2026, an estimated $7.77M.
  • Alkermes made up 0.1% of Loomis, Sayles & Company's portfolio in Q2 2026, its #74 holding.
  • Loomis, Sayles & Company first reported a position in Alkermes in Q2 2013 and has held it in 25 quarters since.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.